Panel Discussion: Reviewing Standards & Regulatory Requirements of the Analytical Field of mRNA-based Therapeutics to Accelerate Approvals

Time: 12:00 pm
day: Conference Day Two


  • Delving into how to give evidence of a state of control and maintain regulatory compliance for your mRNA analytical techniques
  • Revealing how to integrate the new novel mRNA analytical technologies to align with GMP guidelines
  • Understanding how to standardise your mRNA analytical techniques to align to CQA’s & CPI’s to allow efficient and rapid approval